Ultrasensitive and rapid identification of ESRI developer- and piperacillin/tazobactam-resistant Escherichia coli by the MALDIpiptaz test

Background The excessive use of piperacillin/tazobactam (P/T) has promoted the emergence of P/T-resistant Enterobacterales. We reported that in Escherichia coli, P/T contributes to the development of extended-spectrum resistance to β-lactam/β-lactamase inhibitor (BL/BLI) (ESRI) in isolates that are...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Angel Rodríguez Villodres, Lydia Gálvez Benítez, Manuel J. Arroyo, Gema Méndez, Luis Mancera, Andrea Vila Domínguez, José Antonio Lepe Jímenez, Younes Smani
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Taylor & Francis Group 2022-12-01
Saila:	Emerging Microbes and Infections
Gaiak:	Piperacillin tazobactam Escherichia coli resistance beta-lactamase beta-lactamase inhibitor
Sarrera elektronikoa:	https://www.tandfonline.com/doi/10.1080/22221751.2022.2113746
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!